Skip to content

Family Psychoeducation for Major Depressive Disorder

Family Psychoeducation for Major Depressive Disorder - a Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02348827
Enrollment
100
Registered
2015-01-28
Start date
2015-01-31
Completion date
2017-09-30
Last updated
2016-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depressive Disorder

Keywords

Unipolar depression, Family Therapies, Psychoeducation, Family psychoeducation

Brief summary

The aim of the present study is to compare an intervention consisting of Family Psychoeducation (FPE) to an active control intervention of social support for relatives of patients with a diagnosis of major depression.

Detailed description

More than 50 % of patients experiencing their first depressive episode will have at least one new episode. Therefore, effective interventions to reduce the risk of relapse are. Psychoeducation is an interactive education form enhancing knowledge about patients' illness, including it course, symptoms and treatment. Psychoeducational methods can also act as family intervention which already is an evidence-based practice in schizophrenia and bipolar disorder. In spite of unipolar depression's high prevalence, only few studies have focused on the effect of psychoeducation, including family psychoeducation, in the prevention of new depressive episodes. The aim of the present study is to compare an intervention consisting of Family Psychoeducation (FPE) to an active control intervention of social support for relatives of patients with a diagnosis of major depression. The following hypotheses are proposed: 1. Psychoeducational intervention for relatives will reduces the risk of depressive relapse (defined as a score on The Hamilton six-item subscale, HAM-D6≥7), among remitted depressed patients compared to the control condition 2. Psychoeducational intervention for relatives will shorten time to achieve full symptomatic remission (defined as a score HAM-D6\<5) among partially remitted depressed patients compared to the control condition 3. Psychoeducational intervention for relatives will more effectively reduce depressive symptoms (measured on the HAM-D6) among patients fully symptomatic currently depressed patients, compared to control condition. Secondary aims The study has as a secondary goal to investigate whether a high level of expressed emotion (EE) in relatives at baseline will be associated with poorer outcome, in the form of relapse, in depressed patients.

Interventions

Sponsors

Mental Health Centre North Zealand
CollaboratorUNKNOWN
Mental Health Services in the Capital Region, Denmark
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

Patients: Inclusion Criteria: * Age between 18 and 75 * Major depression diagnosis according to the ICD-10 established by a board certified psychiatrist and verified by the MINI International Neuropsychiatric Interview * Living together , or in very regular contact (every day or almost every day), with an adult relative that the patient considers as emotionally important and who are available for intervention Regarding hypothesis 1 and 2, patients will be included if they are in remission or partial remission at the inclusion time defined as a score \<13 on the Hamilton Rating Scale for Depression (HAM-D17) \[20\]. Patients included for the test of hypothesis 3 have a HAM-D17-score \>13 at the time of the inclusion.

Exclusion criteria

* Insufficient knowledge of Danish * Clinical suspicion of dementia * Alcohol, drug or medicine abuse * Psychotic symptoms * Co-morbidity of severe personality disorder * Having undergone ECT treatment during the index depressive episode * Maximum duration of the current depressive episode may not exceed 2 years * Maximum duration of a period with stable remission may not exceed 3 consecutive months Regarding to the relatives following criteria for participation apply: Inclusion criteria: • Age between 18 and 75

Design outcomes

Primary

MeasureTime frameDescription
Number of relpase9 monthsThe primary outcome is relapse defined as a score ≥ 7 on HAM-D6 \[47\] in the 9-month follow-up period (hypothesis 1) among remitted patients.

Secondary

MeasureTime frameDescription
Time to relapseUp to 9 months from baselineThe number of weeks from baseline to relapse, time to full remission defined as a HAM-D6 \<5, among the partially remitted patients (hypothesis 2)
Reduction of depressive symptoms9 monthsReduction of depressive symptoms in the HAM-D6-score (hypothesis 3).

Countries

Denmark

Contacts

Primary ContactNina Timmerby, MD
nina.02.timmerby@regionh.dk+4538643197

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026